These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 7029838)

  • 21. Sputum-smear-negative pulmonary tuberculosis: controlled trial of 3-month and 2-month regimens of chemotherapy.
    Lancet; 1979 Jun; 1(8131):1361-3. PubMed ID: 87829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term follow-up of a clinical trial of six-month and four-month regimens of chemotherapy in the treatment of pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council.
    Am Rev Respir Dis; 1986 May; 133(5):779-83. PubMed ID: 2871788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Five year results of a 3-month and two 5-month regimens for the treatment of sputum-positive pulmonary tuberculosis in south India.
    Balasubramanian R; Sivasubramanian S; Vijayan VK; Ramachandran R; Jawahar MS; Paramasivan CN; Selvakumar N; Somasundaram PR
    Tubercle; 1990 Dec; 71(4):253-8. PubMed ID: 2125153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Operational evaluation of treatment for tuberculosis. Results of 8- and 12-month regimens in Peru.
    Hopewell PC; Ganter B; Baron RB; Sanchez-Hernandez M
    Am Rev Respir Dis; 1985 Oct; 132(4):737-41. PubMed ID: 3901842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short-course chemotherapy for pulmonary tuberculosis under routine programme conditions: a comparison of regimens of 28 and 36 weeks duration in Algeria. Algerian Working Group/British Medical Research Council Cooperative Study.
    Tubercle; 1991 Jun; 72(2):88-100. PubMed ID: 1949222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Study of chemotherapy regimens of 5 and 7 months' duration and the role of corticosteroids in the treatment of sputum-positive patients with pulmonary tuberculosis in South India.
    Tubercle; 1983 Jun; 64(2):73-91. PubMed ID: 6351390
    [No Abstract]   [Full Text] [Related]  

  • 27. Controlled clinical trial of five short-course (4-month) chemotherapy regimens in pulmonary tuberculosis. First report of 4th study. East African and British Medical Research Councils.
    Lancet; 1978 Aug; 2(8085):334-8. PubMed ID: 79708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Present status of chemotherapy for tuberculosis.
    Grosset JH
    Rev Infect Dis; 1989; 11 Suppl 2():S347-52. PubMed ID: 2652251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short-course tuberculosis chemotherapy studies conducted in Poland during the past decade.
    Snider DE; Zierski M; Graczyk J; Bek E; Farer LS
    Eur J Respir Dis; 1986 Jan; 68(1):12-8. PubMed ID: 3512281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre.
    Int J Tuberc Lung Dis; 1997 Dec; 1(6):509-17. PubMed ID: 9487448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Short-course chemotherapy of tuberculosis with pyrazinamide].
    Asai S; Futsuki Y; Tomari S; Araki J
    Nihon Rinsho; 1998 Dec; 56(12):3087-90. PubMed ID: 9883615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of a combined preparation of isoniazid, rifampicin and pyrazinamide (Rifater) in the initial phase of chemotherapy in three 6-month regimens for smear-positive pulmonary tuberculosis: a five-year follow-up report.
    Teo SK
    Int J Tuberc Lung Dis; 1999 Feb; 3(2):126-32. PubMed ID: 10091877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A controlled clinical trial of 3- and 5-month regimens in the treatment of sputum-positive pulmonary tuberculosis in South India. Tuberculosis Research Centre, Madras, and National Tuberculosis Institute, Bangalore.
    Am Rev Respir Dis; 1986 Jul; 134(1):27-33. PubMed ID: 3524334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Controlled clinical trial comparing a 6-month and a 12-month regimen in the treatment of pulmonary tuberculosis in the Algerian Sahara. Algerian working group/British Medical Research Council cooperative study.
    Am Rev Respir Dis; 1984 Jun; 129(6):921-8. PubMed ID: 6375490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short-course chemotherapy of pulmonary tuberculosis in pneumoconiotic patients.
    Lin TP; Suo J; Lee CN; Lee JJ; Yang SP
    Am Rev Respir Dis; 1987 Oct; 136(4):808-10. PubMed ID: 3310770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Controlled trial of 6-month and 9-month regimens of daily and intermittent streptomycin plus isoniazid plus pyrazinamide for pulmonary tuberculosis in Hong Kong. The results up to 30 months.
    Am Rev Respir Dis; 1977 May; 115(5):727-35. PubMed ID: 857713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The effectiveness of pyrazinamide-containing six-month short course chemotherapy].
    Wada M
    Kekkaku; 2000 Nov; 75(11):665-73. PubMed ID: 11140090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Daily ultrashort chemotherapy and intermittent short-term chemotherapy with 4 drugs of communicable pulmonary tuberculosis treated for the first time. Results of a cooperative multicenter study].
    Eule H; Beck H; Evers H; Fischer P; Kwiatkowski H; Merkel S; Reech R; Sieler R; Thomas E; Weinecke W
    Z Erkr Atmungsorgane; 1986; 167(1-2):29-41. PubMed ID: 3532585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Controlled trial of intermittent regimens of rifampicin plus isoniazid for pulmonary tuberculosis in Singapore.
    Lancet; 1975 Dec; 2(7945):1105-9. PubMed ID: 53598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Controlled trial of isoniazid.rifampicin.ethambutol regimen and isoniazid.rifampicin.pyrazinamide regimen in the primary chemotherapy for pulmonary tuberculosis (author's transl)].
    Kekkaku; 1980 Jan; 55(1):7-13. PubMed ID: 6988627
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.